Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
wufuxinnaoqing
- Development stage
- Unknown
- Lead developer
- Xiyuan Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Wufuxinnaoqing is a Traditional Chinese Medicine (TCM) combination product, primarily available as a soft capsule, used for the treatment of cardiovascular and cerebrovascular diseases. The formulation typically contains safflower oil, Alisma (Zexie), rutin, vitamin E, and vitamin B6. It is indicated for chronic stable angina and conditions characterized by blood stasis syndrome. The drug works by promoting blood circulation, lowering blood lipids, and providing antioxidant effects to improve myocardial blood supply. It has been evaluated in multi-center clinical trials in China, including those sponsored by the Xiyuan Hospital of the China Academy of Chinese Medical Sciences, to assess its efficacy and safety in patients with coronary heart disease.
- Brand names
- WufuxinnaoqingWufuxinnaoqing Soft Capsule
- Other names
- Wufuxinnaoqing Soft Capsule
02
Targets
F (Coagulation factors)
Beyond the preview
Go deeper on wufuxinnaoqing.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on wufuxinnaoqing.